Addison’s Disease (Primary Adrenal Insufficiency): Symptoms, Diagnosis & Treatment
Causes, symptoms, diagnosis, treatment, nursing care, and escalation.
Featured snippet
Addison's disease is primary adrenal insufficiency: destruction or dysfunction of the adrenal cortex yielding deficient cortisol and often aldosterone, usually autoimmune in adults in high-income settings. Lifelong glucocorticoid replacement—typically divided oral hydrocortisone—plus mineralocorticoid when electrolytes dictate is paired with urgent escalation pathways for adrenal crisis during physiologic stress.
Clinical snapshot: tie unexplained fatigue, salt craving, hyperpigmentation and upright fainting prompts to sodium–potassium review on the electrolyte panel; confirm with cosyntropin testing where pathways allow.
- Primary vs secondary AI: elevated ACTH with pigmentation cues suggests adrenal destruction—do not anchor solely on random cortisol cut-offs without syndrome context (24 h urinary free cortisol aids subset evaluations guided by endocrinology).
- APS vigilance: newly diagnosed autoimmune Addison's warrants structured screening companions—examples include diabetes type 1, Hashimoto's disease, vitiligo and celiac disease—document prior autoimmune history at handover.
- Crisis triggers: gastroenteritis, surgery without stress dosing and abrupt steroid withdrawal converge on vascular collapse—maintain suspicion when vomiting prevents oral glucocorticoid doses and institute intake/output tracking early.
- Replacement nuance: splitting hydrocortisone mimics diurnal secretion but adherence wins—coordinate pharmacist review when enzyme inducers appear because clearance shifts (dexamethasone lacks mineralocorticoid activity so never substitutes fludrocortisone indications).
- Bedside rhythm: orthostatic blood pressure measurement, glucose checks during illness and accurate steroid administered-times underpin safer titration conversations with endocrine teams.
⚡ Quick Facts
*Titrate to clinical status and guideline pathways—not a standalone prescription instruction.
💡 Clinical Pearl
Hyperpigmentation localisation matters: buccal mucosa, palmar creases and scar-highlighting darkness differentiate ACTH-driven melanocyte stimulation from sun tan alone—yet pigment may be subtle on richly melanised skin, so maintain biochemical suspicion when orthostasis and hyponatraemia cluster without dramatic colour change.
📋 Contents
What is Addison's Disease?
Addison's disease names chronic primary adrenal cortex failure producing inadequate cortisol for metabolic homeostasis and stress responsiveness; mineralocorticoid deficiency frequently accompanies autoimmune adrenal destruction in adults. Cortisol deficits attenuate vascular tone responsiveness, impair gluconeogenesis during fasting stress and blunt anti-inflammatory signalling—explaining hypotension, hypoglycaemia tendency and gastrointestinal intolerance clusters nurses recognise before laboratories normalise.
Distinguishing chronic compensated states from impending crisis hinges on observing trajectory (oral intake, vomiting frequency, orthostatic symptoms, glucose trends) alongside precipitants such as infection or abrupt glucocorticoid withdrawal after prolonged pharmacologic suppression of the hypothalamic–pituitary–adrenal axis.
Forms of adrenal insufficiency
Nurses framing escalation targets clarify whether pathology originates at adrenal level (primary), pituitary ACTH failure (secondary) or chronic glucocorticoid suppression resetting hypothalamic drive (tertiary). Pigmentation and pronounced electrolyte disturbances dominate primary presentations because mineralocorticoid loss exaggerates renal sodium wasting.
| Category | Typical hormone pattern | Clinical implication |
|---|---|---|
| Primary (Addison's) | Low cortisol + high ACTH; salt craving common | Glucocorticoid plus mineralocorticoid pathway review; autoimmune antibody screening. |
| Secondary | Low cortisol + low/inappropriately normal ACTH | Pituitary imaging triggers emerge when MRI clinically justified—replacement avoids abrupt adrenal withdrawal physiology. |
| Tertiary / exogenous suppression | Low cortisol after steroid taper misuse | Stress-cover strategies whenever acute illness overlaps taper phases. |
On a small screen, swipe or scroll sideways to see the full table.
Interpretations vary by assay timing and laboratory harmonisation—mirror local endocrine laboratory manuals rather than memorising isolated numeric myths.
Treat suspected adrenal crisis concurrently while sourcing precipitant labs:
- Systolic hypotension refractory to fluid boluses or relative hypotension versus documented outpatient baseline ≥20 mmHg drop.
- Profound weakness with vomiting preventing oral steroid absorption plus widening sodium–potassium divergence.
- Altered consciousness with concurrent hypoglycaemia—especially known steroid-dependent adults.
Immediate ward actions: activate emergency/medical escalation per protocol, establish IV access and initiate prescribed parenteral hydrocortisone dosing ranges alongside isotonic fluids; draw baseline cortisol/ACTH/electrolytes before bolus hydrocortisone only when sampling logistics do not delay treatment—never postpone rescue steroids solely for phlebotomy convenience.
Symptoms
Insidious onset obscures diagnosis—fatigue overlaps depression, thyroid disorders and anaemia until electrolyte disturbance surfaces. Elderly cohorts emphasise weakness and nausea without vivid pigment clues.
Typical clusters
- Progressive fatigue out of proportion to sleep restoration.
- Hyperpigmentation accentuating scars and mucosa—may be subtle depending on baseline skin tone.
- Nausea, vomiting or diffuse abdominal discomfort mimicking gastroenteritis.
- Salt craving and postural dizziness tying back to mineralocorticoid deficiency physiology.
- Unintentional weight loss with preserved appetite paradox depending on gastrointestinal symptom burden.
Atypical / situational cues
- First presentation during pregnancy—severe hyperemesis-like nausea warrants broader endocrine screening beyond isolated obstetric diagnoses.
- Sudden deterioration triggered by gastroenteritis or minor respiratory infection despite previously stable oral regimen.
- Patients tapering chronic oral steroids presenting with tertiary suppression physiology requiring lengthened physiologic reinstatement timelines.
Causes and Risk Factors
Mechanistic overview
Autoimmune lymphocytic adrenalitis dominates contemporary adult cohorts—often heralded by detectable 21-hydroxylase antibodies supporting APS counselling even before overt electrolyte crises manifest. Infectious adrenalitis (tuberculosis historically prominent globally), metastatic infiltration or adrenal haemorrhage remain geographically and oncologically contextual competitors rarely interchangeable mechanistically.
Risk stratification pearls
- Autoimmune clustering: personal/family histories enriched for type 1 diabetes, autoimmune thyroid disease including hypothyroidism, vitiligo or celiac disease elevate suspicion.
- Medication exposures: chronic supraphysiologic steroids suppress intrinsic cortisol synthesis—withdrawal mismanagement precipitates tertiary crisis physiology.
- Oncologic overlap: bilateral adrenal metastases merit imaging correlation when carcinoma staging unexpectedly unveils electrolyte instability.
How is it Diagnosed?
Clinical assessment
Synthesize orthostasis timing, pigment distribution, gastrointestinal symptom tempo and reversible precipitant exposures—avoid anchoring prematurely on psychiatric diagnoses without corroborative biochemistry.
Laboratory investigations
- Baseline sodium, potassium, glucose plus renal profile contextualising dehydration severity.
- Morning paired cortisol and ACTH guiding referral urgency prior to stimulation testing scheduling.
- Cosyntropin (short Synacthen) stimulation interpreted against assay-specific cortisol thresholds remains guideline-endorsed confirmation backbone.
- Autoimmune serology targeting adrenal cortex antibodies supporting APS longitudinal surveillance cadence.
Imaging
Abdominal CT often demonstrates small non-calcified glands in autoimmune destruction whereas tuberculosis may enlarge glands with necrosis patterns—radiology complements uncertain antibody-negative pathways.
Diagnostic criteria snapshot
| Scenario | Interpretation cue |
|---|---|
| Random cortisol borderline | Repeat timed sampling plus stimulation testing rather than reassurance alone. |
| Hyponatraemia + hyperkalaemia cluster | Suggests mineralocorticoid participation typical of primary AI pending confirmation. |
| Hyponatraemia without pigmentation dominance | Raises secondary AI considerations—coordinate sodium correction guarded protocols owing to seizure risk. |
On a small screen, swipe or scroll sideways to see the full table.
Clinical decision flow
- Suspected chronic AI: arrange paired cortisol + ACTH morning labs → expedite endocrine-led stimulation testing rather than prolonged empirical steroid initiation masking diagnostics unless crisis imminent.
- Confirmed primary AI: initiate guideline-aligned hydrocortisone ± fludrocortisone dosing ladder—titrate orthostasis and electrolytes rather than symptom anecdotes alone.
- Intercurrent illness unable to tolerate oral therapy: escalate per personalised adrenal crisis action plans → IM hydrocortisone access plus acute assessment.
- Perioperative pathway: communicate steroid dependence ≥48 h ahead whenever elective procedures permit—stress dosing escalates proportional to surgical magnitude.
- New enzyme-inducing medicines: pharmacist/endocrine medication reconciliation within roughly two weeks capturing clearance shifts.
Differential Diagnoses
| Alternative | Distinguishing anchors |
|---|---|
| Secondary adrenal insufficiency | Absent/minimal pigmentation; electrolyte disturbance milder unless overlapping renal losses. |
| Salt-wasting nephropathy / renal tubular disorders | Cortisol dynamics intact; urinary concentrating clues diverge. |
| Anorexia / malnutrition states | Weight trajectory differs; stimulation physiology intact unless opioid suppression overlaps. |
| Sepsis-induced hypotension | Fever/source clustering plus lactate trajectory—still maintain steroid deficiency vigilance when antibiotic refractory hypotension persists. |
On a small screen, swipe or scroll sideways to see the full table.
Treatment Options
First-line replacement
- Divided oral hydrocortisone approximating physiologic secretion curves—individualised titration balancing fatigue versus cushingoid features.
- Fludrocortisone when electrolytes/blood pressure demonstrate mineralocorticoid inadequacy despite sodium/fluid optimisation attempts.
- Patient-held steroid emergency cards mirroring NHS/international programmes informing acute teams about dependence.
Second-line / contextual adjustments
- Alternate glucocorticoid preparations considered when absorption unpredictable—requires endocrine prescribing stewardship.
- Stress multipliers doubling/tripling oral doses short spans during vomiting illnesses following personalised crisis leaflets.
- Parenteral hydrocortisone bridging perioperative phases until oral absorption reliably resumes.
Special populations
Pregnancy intensifies sodium/plasma volume demands—coordinate obstetric anaesthesia teams early when neuraxial planning interacts with steroid stress dosing needs. Paediatric dosing proceeds via surface-area equivalents supervised by subspecialists.
Clinical Practice Considerations
- Monitoring cadence: electrolytes within weeks after initiating mineralocorticoid—extend intervals once orthostasis stabilises.
- Drug interactions: rifampicin-class inducers often mandate hydrocortisone uptitration reviews documented alongside clinician acknowledgement timestamps.
- Treatment failure signals: persistent orthostasis or recurrent hyponatraemia despite adherence prompts reassessment for inadequate dosing versus overlapping renal sodium losses.
- Referral thresholds: diagnostic ambiguity, pregnancy planning, perioperative optimisation or unexplained recurrent crises merit tertiary endocrine reassessment windows commonly inside four weeks unless urgent physiology dictates sooner.
Possible Complications
Adrenal crisis conveys mortality despite replacement availability—delayed vasopressor escalation compounds irreversible shock. Chronic overtreatment predisposes osteoporosis and metabolic syndrome mimicry whereas undertreatment fuels recurrent emergency admissions.
- Hyponatraemic seizures during overly rapid sodium correction attempts.
- Hyperkalaemia-mediated dysrhythmias when renal clearance declines concurrently.
- Persistent hypoglycaemia unawareness patterns especially overnight fasting combined illness states.
Prevention
- Structured sick-day teaching reinforcing oral escalation ladders prior to inability to swallow tablets.
- Ensuring injectable hydrocortisone kits remain in-date with caregiver competency reassessment intervals.
- Medication reconciliation whenever ward admissions introduce concealed steroid bursts or antifungals altering metabolism.
Prognosis and Outlook
Modern replacement restores vocational participation when dosing aligns physiology yet subjective fatigue persists disproportionately for subsets—honest counselling avoids implying instantaneous symptom abolition post-prescription alone.
In Clinical Practice…
Nurses anchor multidisciplinary safety nets translating opaque endocrine pathways into observable nursing-sensitive indicators.
- Chart orthostatic vitals systematically—not isolated lying readings obscuring subtle collapses.
- Capture precise timestamps for steroid doses aligning pharmacokinetics interpretation during crises.
- Barrier-aware education ensuring linguistic accessibility for adrenaline injector technique rehearsal.
Bedside monitoring checklist
- Orthostatic blood pressure paired pulse recordings each shift during instability phases.
- Strict intake/output balances during vomiting gastroenteritis bridging crises.
- Point-of-care glucose surveillance each four-to-six hours during acute illness pathways unless protocols tighten intervals.
- Medication allergy cross-check preventing accidental beta-blockade masking tachycardia compensatory clues.
When to Seek Emergency Care
- Collapse or persistent vomiting preventing oral steroid absorption.
- New neurological deficits coinciding sodium derangements.
- Severe abdominal pain mimicking acute abdomen plus refractory hypotension.
Activate emergency services aligned with jurisdictional pathways—even after appropriate IM steroid rescue—because electrolyte reassessment continues inpatient.
Deterioration & escalation
- Vitals: widening pulse pressure inversion plus mucous membrane dryness implies escalating dehydration.
- Laboratory: sodium trending downward across serial draws absent corrective therapy warrants senior review hourly cadence contexts.
- Escalation: involve ICU/high-dependency criteria teams when lactate rises despite fluids or vasopressor dependency emerges outside baseline expectations.
Nursing management
Pre-treatment / admission
- Rapid bedside glucose verification alongside electrolyte panels drawn according to escalation urgency.
- Warm simultaneous communication lines linking emergency physicians with endocrine on-call recommendations.
Post-stabilisation
- Reconcile inpatient steroid doses against outpatient personalised crisis leaflets preventing accidental discontinuation overnight.
- Psychological distress screening acknowledging fatigue-associated depression mimic loops.
Education evaluation
- Teach-back verification demonstrating IM injector competency plus recognise expiry rotation logistics.
NCLEX practice questions
These NCLEX-style clinical judgment practice items focus on the nursing priorities for this condition — recognise cues, escalate red flags, take safe action and evaluate outcomes (NCSBN Clinical Judgment Measurement Model) — through Priority FIRST, SATA, deterioration trends, multi-patient triage, ordered response, matrix matching and cloze drops on the topic of primary adrenal insufficiency, the biochemical signature (low Na⁺, high K⁺, low cortisol with high ACTH), Synacthen testing, hydrocortisone + fludrocortisone replacement, and Addisonian-crisis sick-day rules.
Unfolding case (Questions 1–3): Mrs. C., 42, with known autoimmune Addison’s disease for 5 years on oral hydrocortisone 10–5–5 mg and fludrocortisone 100 µg daily, presents to ED after 36 hours of severe vomiting from gastroenteritis. She did not take her hydrocortisone today. On arrival: BP 78/44, HR 128, T 38.4 °C, drowsy. Labs: Na⁺ 128 mmol/L, K⁺ 5.8 mmol/L, glucose 3.2 mmol/L, creatinine 160 µmol/L.
Answer key & rationale
Why do routine morning cortisol interpretations frustrate bedside clinicians in suspected primary adrenal insufficiency?
Single random cortisol samples overlap substantially between health and disease; guideline-era pathways combine indicative symptoms with paired ACTH and cortisol interpretation or proceed to cosyntropin (short Synacthen) testing rather than relying on one isolated lab draw timing alone.
How quickly should outpatient hydrocortisone doses change after introducing enzyme-inducing drugs or new hormonal contraception?
Enzyme inducers often demand sooner endocrine/pharmacy review because hepatic metabolism shifts glucocorticoid clearance—many pathways specify reassessment within roughly two weeks of co-prescription unless urgent symptoms emerge sooner.
When can nurses anticipate fludrocortisone titration visits after initiation?
Electrolyte-focused reviews commonly cluster in the early titration phase—often within roughly two to four weeks—then extend once blood pressure, sodium and potassium stabilize on standing assessments aligned with local endocrine protocols.
Does every diarrhoeal illness mandate identical oral stress-dose multiples across programmes?
No—patient-specific adrenal crisis plans spell multiples and escalation thresholds; inability to retain oral hydrocortisone or deteriorating perfusion shifts management toward parenteral steroid and urgent assessment irrespective of textbook multiples alone.
Which autoimmune companions belong on proactive laboratory radar once 21-hydroxylase antibodies confirm autoimmune Addison's?
Autoimmune thyroid disease and type 1 diabetes mellitus exemplify APS clustering merits periodic thyroid function and glucose surveillance guided by endocrinology pathways—not reactive testing only after symptoms dominate.
Why distinguish adrenal crisis hypotension from septic shock before steroids arrive?
Treatment overlaps supportive fluids and vasopressors, yet infectious triggers still warrant cultures and antimicrobial timelines where indicated—rapid hydrocortisone replacement treats cortisol deficiency while parallel pathways hunt reversible precipitants.
Should dexamethasone replace hydrocortisone for sick-day oral escalation at home?
Dexamethasone lacks mineralocorticoid activity and differs from ward hydrocortisone-centred crisis kits—patient-held emergency instructions should mirror what prescribing teams documented rather than swapping agents ad hoc.
How often repeat DXA or fracture-risk counselling enter nursing discharge teaching for stable replacement therapy?
Glucocorticoid exposure—even physiological replacement—prompts bone health conversations on specialist schedules; nurses reinforce adherence with calcium/vitamin D guidance where prescribed and flag fragility fractures early.
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Definition & Facts of Adrenal Insufficiency & Addison's Disease.niddk.nih.gov/health-information/endocrine-diseases/adrenal-insufficiency-addisons-disease/definition-facts
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Symptoms & Causes of Adrenal Insufficiency & Addison's Disease.niddk.nih.gov/health-information/endocrine-diseases/adrenal-insufficiency-addisons-disease/symptoms-causes
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Diagnosis of Adrenal Insufficiency & Addison's Disease.niddk.nih.gov/health-information/endocrine-diseases/adrenal-insufficiency-addisons-disease/diagnosis
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Treatment of Adrenal Insufficiency & Addison's Disease.niddk.nih.gov/health-information/endocrine-diseases/adrenal-insufficiency-addisons-disease/treatment
- NHS UK. Addison's disease.nhs.uk/conditions/addisons-disease
- Healthdirect Australia. Addison's disease (primary adrenal insufficiency).healthdirect.gov.au/addisons-disease
- Bornstein SR, et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016.pubmed.ncbi.nlm.nih.gov/26760044
- Rushworth RL, Torpy DJ, Falhammar H. Adrenal Crisis. N Engl J Med. 2019.pubmed.ncbi.nlm.nih.gov/31461595
- Huecker MR, Bhutta BS, Dominique E. Adrenal Insufficiency. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan.ncbi.nlm.nih.gov/books/NBK441832
- Elshimy G, et al. Addisonian Crisis. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan.ncbi.nlm.nih.gov/books/NBK441933